RTSN
Retension Pharmaceuticals Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$14.07
+15.23%2
Insider buys (3m)
0
Insider sells (3m)
$369.6K
Net value (3m)
—
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 13, 2026 | Keller Eric L. · director, officer: CHIEF EXECUTIVE OFFICER | Purchase | 20,800 | $12 |
| Oct 13, 2026 | Keller Eric L. · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 255,174 | $12 |
| Oct 13, 2026 | Cheruvu Pavan · director | A-Award | 5,636 | $12 |
| Oct 13, 2026 | BERGER FRANKLIN M · director | Purchase | 10,000 | $12 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 13, 2026